Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-27
1999-08-03
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514300, 514301, 546 14, 546 18, 546114, 546116, 546122, 546123, C07D47104, C07D49504, A61K 31435
Patent
active
059325879
ABSTRACT:
The heterocyclic-fused pyridines are prepared by reaction of the corresponding heterocyclic-fused pyridine aldehydes with appropriately substituted Grignard or Wittig reagents. The heterocyclic-fused pyridines are suitable as active compounds in medicaments, in particular in medicaments for the treatment of dislipidaemia and arteriosclerosis.
REFERENCES:
patent: 4814346 (1989-03-01), Albert et al.
patent: 5006530 (1991-04-01), Angerbauer et al.
patent: 5034399 (1991-07-01), Hubsch et al.
patent: 5169857 (1992-12-01), Angerbauer et al.
Tetrahedron. vol. 40. No. 18. pp. 3431-3436, 1984, Ramesch. M. et al. Synthesis of 2-isopropylfuro (2.3-b) quinolines.
Monatsh. fur Chemie (1976), 107 (1), pp. 259-269. Shanmugan. P., et al.
Angerbauer Rolf
Bischoff Hilmar
Brandes Arndt
Bremm Klaus-Dieter
Logers Michael
Bayer Aktiengesellschaft
Dentz Bernard
LandOfFree
Heterocyclic-fused pyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic-fused pyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic-fused pyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849742